Pangenomic Health Inc. NARA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 130.30K | 204.30K | 274.20K | 531.80K | 542.40K |
| Gross Profit | -130.30K | -204.30K | -274.20K | -531.80K | -542.40K |
| SG&A Expenses | 2.63M | 2.45M | 2.01M | 1.57M | 527.00K |
| Depreciation & Amortization | 400.00 | 400.00 | 400.00 | 400.00 | 1.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.76M | 2.66M | 2.28M | 2.10M | 1.07M |
| Operating Income | -2.76M | -2.66M | -2.28M | -2.10M | -1.07M |
| Income Before Tax | -3.07M | -2.87M | -2.47M | -2.45M | -1.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.07 | -2.87 | -2.47 | -2.45 | -1.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.07M | -2.87M | -2.47M | -2.45M | -1.31M |
| EBIT | -2.76M | -2.66M | -2.28M | -2.10M | -1.07M |
| EBITDA | -2.76M | -2.66M | -2.28M | -2.10M | -1.07M |
| EPS Basic | -0.15 | -0.15 | -0.17 | -0.25 | -0.19 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.10 | -0.14 | -0.10 |
| EPS Diluted | -0.15 | -0.15 | -0.17 | -0.25 | -0.19 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.10 | -0.14 | -0.10 |
| Average Basic Shares Outstanding | 92.60M | 80.93M | 62.57M | 42.12M | 32.94M |
| Average Diluted Shares Outstanding | 92.60M | 80.93M | 62.57M | 42.12M | 32.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |